Fitbit Labs Introduces ‘Unusual Trend Detection’ and Hypertension Study for Pixel Watch 3 Users
Fitbit Labs is expanding its suite of health-focused features with the introduction of two new experimental capabilities: ‘Unusual Trend Detection’ and a Hypertension Study specifically designed for Pixel Watch 3 users.
Unusual Trend Detection
The ‘Unusual Trend Detection’ feature is designed to alert users when their health metrics deviate from established personal baselines. By continuously monitoring various health indicators, this tool aims to provide timely notifications about significant changes, enabling users to take proactive steps toward their well-being. Upon receiving an alert, users can log potential causes and symptoms, receive recommendations for rest and recovery, and track when their metrics return to typical patterns. It’s important to note that this feature is intended for research exploration and is not a substitute for professional medical advice.
Hypertension Study for Pixel Watch 3 Users
In addition to the trend detection feature, Fitbit Labs is launching a Hypertension Study targeting Pixel Watch 3 users. The study aims to utilize data from the Pixel Watch 3 to identify early signs of high blood pressure. Fitbit is seeking up to 10,000 eligible participants in the United States to wear their Pixel Watch 3 as usual for a period of 180 days. A subset of these participants will be provided with an Ambulatory Blood Pressure Monitoring cuff to wear for 24 hours, with a $25 gift card offered as compensation upon return of the device.
Participants may experience a slight, temporary change in their watch’s battery life during the study, but it is expected to last a full day on a single charge. Interested individuals can join the study by accessing the Fitbit Labs page on their Android devices and following the provided instructions.
Data Usage and Privacy
Fitbit emphasizes that data collected during these experimental features will be used for research and development purposes to improve future health features. The data is not intended to provide individual health insights or assessments within the scope of these labs. Survey responses will be used to identify participants who meet the inclusion criteria, and user profile information will verify participation in the research study.
Conclusion
These initiatives by Fitbit Labs underscore the company’s commitment to advancing health monitoring technologies and providing users with tools to better understand and manage their health. By participating in these experimental features, users contribute to the development of innovative health solutions that may benefit the broader community in the future.
